Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Image-guided Focal Brachytherapy with 18F-DCFPyl PET/CT for Localized Prostate Cancer
NCT03861676Phase 1Recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Percent tumor coverage at 30 days. Started Aug 2023; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03861676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03861676.